Is Berberine Lipid Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Berberine Lipid Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Diabetes mellitus and prediabetes represent major global health challenges associated with metabolic and cardiovascular complications. [Nampalliwar A (2026); evidence level 1] - This review was conducted to evaluate herbal medicines as complementary strategies for glycaemic control and metabolic risk reduction. [Nampalliwar A (2026); evidence level 1] - Berberine lowers both lipids and glucose, yet its role on cardiometabolic disease risk remain unclear. [Zhao JV (2026); evidence level 2] - Based on a randomized controlled trial of berberine (registered in ClinicalTrials.gov on Dec 2018, NCT03770325), leveraging proteomics and sex hormones data, we built a signature reflecting response to berberine using elastic net regression. [Zhao JV (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.